title: Early discharge using five french guiding catheter for transfemural coronary stenting: a feasibility and safety study (EDU 5Fr study).
abstract: This study assessed the safety and efficacy of early discharge after percutaneous coronary intervention (PCI) using 5Fr guiding catheters with a femoral approach in 100 patients undergoing elective coronary stenting. Patients were treated with aspirin and thienopyridines for 72 hours before PCI, and unfractionated heparin 70 IU/kg (< or = 5,000 IU) intravenously after arterial puncture. PCI was performed by femoral access using 5Fr guiding catheters and immediate postprocedural arterial sheath removal. Patients were discharged within 8 to 12 hours. No closure devices were used. Early discharge using 5Fr catheters was successful in 97% of cases. No deaths, myocardial infarction, or vascular complications occurred at 24 hours and 30 days.
authors.affiliation: Centre for Cardiovascular Research and Division of Interventional Cardiology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Lasevitch
authors.forename: Raquel
authors.initials: R
authors.lastname: Melchior
authors.forename: Vitor
authors.initials: V
authors.lastname: Gomes
authors.forename: Caroline
authors.initials: C
authors.lastname: Berg
authors.forename: Marcelo
authors.initials: M
authors.lastname: Roman
authors.forename: Rafael
authors.initials: R
authors.lastname: Alcalde
authors.forename: Alberto A
authors.initials: AA
authors.lastname: Brizolara
authors.forename: Paulo
authors.initials: P
authors.lastname: Caramori
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation* / Q000379:methods*; D001241:Aspirin / Q000008:administration & dosage; D005240:Feasibility Studies; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010351:Patient Discharge; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011446:Prospective Studies; D011725:Pyridines / Q000008:administration & dosage; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; C446540:thienopyridine; D006493:Heparin; D001241:Aspirin